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erence for DBS over CDLCI (OR 8.02, 95% CI6.17-10.38). Avoiding deterioration in
movement was also important in determining treatment choice (OR0.67;
95%CI0.57-0.79) as was avoiding limitations on daily activities; (OR0.69;
95%CI0.54-0.88). CONCLUSIONS: CPD patients were able to engage in this quite
complex task to indicate their views regarding treatments. Participants had a pref-
erence for DBS surgery type. Maintaining movement and daily activities were also
important attributes. As the surgery attribute was a composite of both surgical
procedure and daily maintenance, further study is needed to identify which of
these aspects is the strongest predictor of patient preferences. Finally, a larger
study is needed to understand the importance of attributes for all the treatment
alternatives that can be offered to CPD patients
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OBJECTIVES: To develop and subsequently evaluate content validity of questions
assessing patient preference between two dry powder inhaler (DPI) devices (the
Handihaler and the Novel DPI) for the treatment of chronic obstructive pulmonary
disease (COPD), based on ease of use. METHODS: Initial COPD Device Preference
Questionnaire (CDPQ) items were designed to assess inhaler device preference
based on aspects of ease of use identified as important by COPD patients and
physicians during previous research. Two iterative rounds of semistructured, in-
depth interviews were conducted in adult patients currently receiving COPD med-
ication via the Handihaler. Initially, patients were asked to describe the actuation
of the Handihaler. Next, the features and steps required to operate the Novel DPI
were described, and participants were asked to demonstrate using an empty de-
vice. Cognitive debriefing of the CDPQ was then conducted. Patients completed and
evaluated five items, each phrased two different ways (beginning with “which. . .”
or “thinking. . .”). Round 1 interviews (n 8) gathered feedback on preferred phras-
ing and modifications required to improve the CDPQ. Round 2 interviews (n  8)
assessed modifications and gathered additional input to confirm content validity.
All interviews were recorded and transcribed for analysis. RESULTS: Round 1 in-
terviews resulted in addition of instruction detail, modification of questions based
on a clear preference for the “which” phrasing, and removal of two items (i.e.,
understanding how to use the device and number of steps involved in preparing
the device) deemed duplicative. Round 2 interviews did not result in additional
changes. Participants found instructions, items, and response wording easy to
understand and complete. An item-tracking grid was constructed to summarize
item changes and their rationales. CONCLUSIONS: Participant feedback indicates
that the concepts of greatest importance in determining COPD inhaler device pref-
erence related to ease of use were reflected in the final CDPQ items.
PMD61
THE EFFECTS OF SUBJECTIVE INSOMNIA PATTERN ON THE QUALITY OF LIFE
OF THE CLIMACTERIC WOMEN IN TAIWAN
Wu HC1, Lai JN2, Hwang JS3
1Buddist Tzu-Chi General Hosipital, New Taipei, Taiwan, 2National Yang-Ming University,
Taipei, Taiwan, 3Academia Sinica, Taipei, Taiwan
OBJECTIVES: Sleep issues are relevant to women across their whole lifespan and
this is especially true during the climacteric period. Previous studies have demon-
strated that insomnia influences quality of life (QOL) across various different do-
mains. However, the different characteristics of the insomnia that influences the
QOL remain unclear. Our study was designed to investigate which type of insomnia
influences the health-related quality of life amongst women. METHODS: A total of
1098 women age between 40-60 years seeking medical advice were drawn from two
hospital, with a further 314 healthy referents of the same age, range and gender,
with no history of hormone replacement therapy and living in the same munici-
pality, also being recruited from a national health survey sample for comparison.
Each one was asked to fill out a brief questionnaire, the Taiwan version of the
World Health Organization Quality of life (WHOQOL-BREF), which assesses quality
of life based on 26 items in four domains (physical, psychological, social and envi-
ronmental). In addition, the Pittsburgh sleep quality index (PSQI) was used to eval-
uate the sleep quality and insomnia pattern of the subjects. Multiple regression
analyses were conducted to control variables such as age, marital status, religion,
educational attainment and menopausal status. RESULTS: The mean total score of
the PSQI was 7.5  3.8 with a range from 0-20. In the 1098 participants, 65.3%
(n717) were confirmed to be poor sleepers, and 34.7% (n381) were good sleepers.
After controlling for the demographic factors, it was found that subjective poor
sleep quality and daytime dysfunction were the major determinants of the scores
in the different domains. CONCLUSIONS: A high incidence of poor sleep quality
exists among climacteric women in the urban area of Taiwan and subjective poor
sleep quality and poor daytime function should be taken into consideration in the
management of climacteric women seeking medical advice.
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OBJECTIVES: The objective of this study was to validate clinician and patient mea-
sures of satisfaction and preference for pharmacological stress agents (PSAs) used
in Single Photon Emission Computed Tomography (SPECT) Myocardial perfusion
imaging (MPI) procedures using classical and novel psychometric methods.
METHODS: Psychometric validation of the Clinician Satisfaction and Preference
Questionnaire (CSPQ) and the Patient Satisfaction and Preference Questionnaire
(PSPQ) was conducted in a sample of 90 patients and 15 clinicians. Due to the small
sample size, a Bayesian Item Response Theory was utilized to validate the initial
parameter estimates. Specifically, item difficulty was evaluated using patient char-
acteristics as the known prior distributions. RESULTS: The CSPQ demonstrated
strong internal consistency (alpha0.99) and moderate point-biserial correlations
between PSA satisfaction scores and agent preference (range 0.63-0.65). The PSPQ
‘preparation’ and ‘reaction to agent’ scales demonstrated strong internal consis-
tency (alpha0.90 and 0.87 respectively). Test-retest reliability was acceptable for
all PSPQ scales (ICC range0.73 to 0.86). Concurrent validity with the Treatment
Satisfaction Questionnaire for Medication (TSQM) indicate low to moderate corre-
lations between the Effectiveness, Convenience and Global Satisfaction scales of
the TSQM with the PSPQ Satisfaction with Administration, Satisfaction with Effects
and Overall Satisfaction items (range 0.46 to 0.78). The results of the Bayesian
analysis indicated consistency between the two approaches. Specifically, item dif-
ficulty was invariant across the various patient demographics.CONCLUSIONS:The
CSPQ and PSPQ were developed and validated using rigorous, gold standard meth-
odology. The resulting instruments sufficiently represents meaningful domains
demonstrate strong internal consistency, good test-retest reliability, and predic-
tive validity associated with clinician and patient measures of satisfaction and
preference for pharmacological stress agents (PSAs) used in Single Photon Emis-
sion Computed Tomography (SPECT) Myocardial perfusion imaging (MPI) proce-
dures. The variance in the item parameters were fully explained by the summary
demographic information on the patients and physicians as supported by the
Bayesian analysis.
Medical Device/Diagnostics – Health Care Use & Policy Studies
PMD63
COST-BENEFIT ANALYSIS OF CT CONTRAST MEDIA (IOPROMIDE) WITH
PREFILLED CARTRIDGE TYPE COMPARED TO GLASS BOTTLE TYPE
Kim J1, Park S1, Boo Y2, Lee E1, Tang J1, Jeong S1
1Seoul National University, Seoul, South Korea, 2Eulji University, Gyeonggi-do, South Korea
OBJECTIVES: In CT imaging, as preparation procedure for contrast media (Iopro-
mide), the use of prefilled cartridge (PFC) is simpler compared to glass bottle (GB).
There are several benefits such as infection control and time saving. This study
examined the benefits of contrast media with PFC compared to GB.METHODS: The
benefits are defined as the cost savings which can occur when used in various
situations. A decision analytic model was created to evaluate the effectiveness
according to the type. The use of each type could finally lead to local infection and
blood stream infection (BSI). We estimated the benefits using the probability of
infection from decision model and treatment costs from insurance claims data. To
estimate the benefits of time saving, we measured the preparation time repeatedly
in general hospitals. Assuming that the reduced time was replaced with CT scan in
new patients, we estimated the time saving benefits by multiplying the result to the
cost of CT scan. RESULTS: The material cost of GB was $74.8 which is higher than
$72.9 of PFC. In contrast, in case of GB, the probability of contamination, local
infection and BSI were 3.3%, 1.25%, 0.060% respectively, which were higher than
PFC (0%, 1.22%, 0.058%). The benefit in reduction of infection was estimated at $0.20
per case in PFC. The reduced time from using PFC has an average of 51.9 seconds
based on 113 observations from 3 general hospitals. The time saving benefit was
estimated at $7.16 per case. Therefore, the total benefit was estimated at $7.36.
CONCLUSIONS:This study showed that PFC dominated GB (lower costs, and higher
benefits). This was driven by lower material cost, lower infection risk and admin-
istration time for PFC compared to GB. Findings of this study suggest that the use of
PFC contrast media is an efficient utilization of resources in Korea.
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OBJECTIVES: The aim of the study was to measure the effect of supplementary fees
on the use of drug-eluting stents (DES) in AMI patients instead of conventional
bare-metal stents (BMS). German DRG fees do not distinguish between different
types of coronary stents. To compensate hospitals for higher costs of DES, supple-
mentary payments could be negotiated between the hospital and the sickness
funds.METHODS:Administrative data of one of the largest German sickness funds
was used to identify the determinants of DES use in AMI patients. The dataset
contained information on demographic characteristics and co-morbidities on pa-
tient level. Information on hospital and regional level including the supplementary
fee for the use of DES was merged. 9.453 patients with an admission due to an AMI
and the implantation of a BMS or DES between 2004 through to 2006 were included
in the analysis. For analyzing the data, a logistic multilevel regression approach
was used; the dependent variable was binary, taking the value of 1 if a DES was
implanted and 0 if a BMS was implanted. In the regression, a comprehensive set of
covariates on patient level as well as variables on hospital and regional level were
included. To test robustness of the estimation, several models were estimated.
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